GeneDx Holdings Corp. - Warrant — Statistiche Finanziarie Trimestrali (NASDAQ:WGSWW) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -3.18 M10.18 M10.42 M15.77 M-3.09 M-32.41 M -9.31 M Flussi di cassa derivanti dalle attività di investimento -519 K-9.41 M-36.35 M-4.69 M-11.07 M-17.25 M -69.36 M Liquidità derivante dalle attività di finanziamento 31.02 M13.72 M346 K10.77 M23.19 M38.59 M 72.9 M Liquidità libera -3.18 M10.18 M8.05 M9.6 M-7.44 M-38.86 M -28.65 M

Notizie

GeneDx: Disappointing Q1 Creates Another Turnaround Opportunity (NASDAQ:WGS)

Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)

GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth (NASDAQ:WGS)

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

GeneDx Holdings Corp. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:WGS)

Macquarie Small Cap Growth Fund Q1 2025 Commentary (WGSWW)

Harbor Health Care ETF Q1 2025 Commentary (undefined:MEDI)

Invesco Health Care Fund Q4 2024 Commentary

GeneDx: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy' (NASDAQ:WGS)

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript